HMOX1 and ablepharon macrostomia syndrome: Recently, it has been recognized that activation of the Nrf2/HO-1 pathway is beneficial in treating cardiovascular disorders including ischemic heart disease, arrhythmia, and heart failure, as well as in preventing the AMS (Lisk et al. 2013; Smith et al. 2016; Lu et al. 2020).